IMC Chicago
ADMA icon

IMC Chicago’s ADMA Biologics ADMA Stock Holding History

IMC Chicago’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.31M Sell
156,000
-31,300
-17% -$285K ﹤0.01% 3520
2026
Q1 		$1.69M Buy
187,300
+67,100
+56% +$1.06M ﹤0.01% 2744
2025
Q4 		$2.19M Buy
120,200
+68,800
+134% +$1.16M ﹤0.01% 2333
2025
Q3 		$754K Buy
51,400
+20,700
+67% +$355K ﹤0.01% 2912
2025
Q2 		$559K Sell
30,700
-1,200
-4% -$24.5K ﹤0.01% 2800
2025
Q1 		$633K Buy
31,900
+16,000
+101% +$277K ﹤0.01% 2534
2024
Q4 		$273K Buy
+15,900
New +$299K ﹤0.01% 3008

Other funds holding ADMA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

IMC Chicago's ADMA Position: Q2 2026 in Review

IMC Chicago reduced its ADMA Biologics (ADMA) stake by 29% in Q2 2026, selling an estimated $164K and leaving 44,092 shares worth $369K. The position accounts for ﹤0.01% of the portfolio, ranked #4986.

IMC Chicago first reported a position in ADMA in Q2 2025 and has held it in 5 quarters since. The position peaked at $559K in Q1 2026. 323 funds tracked by Wall St. Rank hold ADMA as of Q2 2026.

  • IMC Chicago held 44,092 shares of ADMA Biologics worth $369K as of Q2 2026.
  • IMC Chicago sold 17,983 ADMA Biologics shares in Q2 2026, an estimated $164K.
  • ADMA Biologics made up ﹤0.01% of IMC Chicago's portfolio in Q2 2026, its #4986 holding.
  • IMC Chicago first reported a position in ADMA Biologics in Q2 2025 and has held it in 5 quarters since.
  • IMC Chicago's ADMA Biologics position peaked at $559K in Q1 2026.
  • 323 funds tracked by Wall St. Rank held ADMA Biologics as of Q2 2026.

Based on IMC Chicago's 13F filing for Q2 2026, filed 6 Aug 2026.